Calculation of Filing Fee Tables
Form S-3
(Form Type)
Avalo Therapeutics, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered and Carry Forward Securities
| | | | | | | | | | | | | | | | | | | | | | | | | | |
| Security Type | Security Class Title | Fee Calculation or Carry Forward Rule | Amount Registered (1) | Proposed Maximum Offering Price Per Unit (2) | Maximum Aggregate Offering Price (2) | Fee Rate | Amount of Registration Fee (3) |
Newly Registered Securities |
Fees to Be Paid | Equity | Common Stock, par value $0.001 per share | | | | | | |
| Equity | Preferred Stock, par value $0.001 per share | | | | | | |
| Debt | Debt Securities | | | | | | |
| Other | Warrants | | | | | | |
| Other | Units | | | | | | |
| Unallocated (Universal) Shelf | — | 457(o) | (1) | (2) | $375,000,000 | 0.00011020 | $41,325 |
Fees Previously Paid | | | | | | | | |
Carry Forward Securities |
Carry Forward Securities | — | — | — | — | — | — | | — |
| Total Offering Amounts | | $375,000,000 | 0.00011020 | $41,325 |
| Total Fees Previously Paid | | — | | $0 |
| Total Fee Offsets | | — | | $0 |
| Net Fee Due | | | | $41,325 |
(1) There are being registered under this registration statement such indeterminate number of shares of common stock, preferred stock, debt securities, warrants and/or units of the registrant as shall have an aggregate initial offering price not to exceed $375,000,000. Any securities registered under this registration statement may be sold separately or as units with other securities registered under this registration statement. The securities registered also include such indeterminate number of securities that may be issued upon exercise, settlement, exchange or conversion of securities offered or sold hereunder. Separate consideration may or may not be received for securities that are issuable upon conversion, exercise or exchange of other securities. The amount of each class of securities being registered under this registration statement is not specified pursuant to General Instruction II.D. of Form S-3 under the Securities Act of 1933, as amended (the “Securities Act”). In addition, pursuant to Rule 416 under the Securities Act, there are also being registered an indeterminable number of securities as may be issued with respect to prevent dilution resulting from stock splits, stock dividends or similar transactions.
(2) The proposed maximum offering price per unit or security will be determined, from time to time, by the registrant in connection with the issuance by the registrant of the securities registered hereunder and is not specified as to each class of security pursuant to Instruction 2.A.iii.b. to the Calculation of Filing Fee Tables and Related Disclosure on Item 16(b) of Form S-3 under the Securities Act.
(3) Estimated in accordance with Rule 457(c) under the Securities Act.